|
Contents |
|
|
|
Diagnosis
& Evaluation
|
|
Epidemiology
& Risk Factors
|
|
Etiology & Pathogenesis
|
|
Integrative
Medicine
|
|
Prognosis
& Outcome
|
|
Treatment
|
|
|
|
|
Diagnosis
& Evaluation
|
|
|
|
|
Mardor
Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R,
Glicksman A, Baram J, Orenstein A, Cohen JS, Tichler T [*]
Early
Detection of Response to Radiation Therapy in Patients With Brain
Malignancies Using Conventional and High b-Value Diffusion-Weighted
Magnetic Resonance Imaging
J Clin Oncol 2003 Mar 15;21(6):1094-100
|
|
|
Epidemiology
& Risk
Factors
|
|
|
|
|
O'Neill
BP, Blondal H, Yang P, Olafsdottir GH, Sigvaldason H, Jenkins RB,
Kimmel DW, Scheithauer BW, Rocca WA, Bjornsson J, Tulinius H
Risk
of cancer among relatives of patients with glioma
Cancer Epidemiol Biomarkers Prev 2002 Sep;11(9):921-4
|
|
|
Etiology & Pathogenesis
|
|
|
|
|
Bagga
D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST
Differential
effects of prostaglandin derived from omega -6 and omega -3
polyunsaturated fatty acids on COX-2 expression and IL-6 secretion
Proc Natl Acad Sci U S A 2003 Feb 18;100(4):1751-6
|
|
|
Berry
EM
Who's
afraid of n-6 polyunsaturated fatty acids? Methodological
considerations for assessing whether they are harmful
Nutr Metab Cardiovasc Dis 2001 Jun;11(3):181-8
|
|
|
Integrative
Medicine
|
|
|
|
|
Beuth
J, Ost B, Pakdaman A, Rethfeldt E, Bock PR, Hanisch J, Schneider B
Impact
of complementary oral enzyme application on the postoperative treatment
results of breast cancer patients--results of an epidemiological
multicentre retrolective cohort study
Cancer Chemother
Pharmacol 2001 Jul;47 Suppl:S45-54
|
|
|
Desser
L, Holomanova D, Zavadova E, Pavelka K, Mohr T, Herbacek I
Oral
therapy with proteolytic enzymes decreases excessive TGF-beta levels in
human blood
Cancer Chemother Pharmacol 2001 Jul;47 Suppl:S10-5
|
|
|
Ilc K, Ferrero JM,
Fischel JL, Formento P, Bryce R, Etienne MC, Milano G [**]
Cytotoxic
effects of two gamma linoleic salts (lithium gammalinolenate or meglumine
gammalinolenate) alone or associated with a nitrosourea: an experimental
study on human glioblastoma cell lines
Anticancer
Drugs 1999 Apr;10(4):413-7
|
|
|
Vartak S, McCaw R, Davis CS, Robbins ME, Spector AA [**]
Gamma-linolenic
acid (GLA) is cytotoxic to 36B10 malignant rat astrocytoma cells but not
to 'normal' rat astrocytes
Br J Cancer 1998
May;77(10):1612-20
|
|
|
Pace A, Savarese A,
Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C,
Jandolo B, Cognetti F, Bove L
Neuroprotective
effect of vitamin e supplementation in patients treated with Cisplatin
chemotherapy
J Clin Oncol 2003 Mar 1;21(5):927-31
|
|
|
Prognosis
& Outcome
|
|
|
|
|
Hakin-Smith
V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ,
Reddel RR, Royds JA
Alternative
lengthening of telomeres and survival in patients with glioblastoma
multiforme
Lancet 2003 Mar 8;361(9360):836-8
|
|
|
Treatment
|
|
|
|
|
Fazeny-Dorner
B, Veitl M, Wenzel C, Rossler K, Ungersbock K, Dieckmann K, Piribauer
M, Hainfellner J, Marosi C
Survival
with dacarbazine and fotemustine in newly diagnosed glioblastoma
multiforme
Br J Cancer 2003 Feb 24;88(4):496-501
|
|
|
Chamberlain
MC, Kormanik PA
Salvage
chemotherapy with tamoxifen for recurrent anaplastic astrocytomas
Arch Neurol 1999
Jun;56(6):703-8
|
bottom
|
Volume 2, Number 7 - 28 March 2003